Tiziana CEO Ivor Elrifi acquires 667,000 common shares for $667,000
TLSA•CEO reports indirect share purchase
- Tiziana Life Sciences CEO Ivor Elrifi reported an indirect purchase of 667,000 common shares at USD 1 per share.
- Indirect holdings held by trust increased to 4,472,261 common shares.




